298
Views
11
CrossRef citations to date
0
Altmetric
Research Article

High-throughput virtual screening approach of natural compounds as target inhibitors of plasmepsin-II

, , , , &
Pages 10070-10080 | Received 18 Jul 2022, Accepted 23 Nov 2022, Published online: 05 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Anis Ul Islam, Hanine Hadni, Ferdausi Ali, Abdelsalam Abuzreda & Sarkar M. A. Kawsar. (2024) Synthesis, antimicrobial activity, molecular docking, molecular dynamics simulation, and ADMET properties of the mannopyranoside derivatives as antimicrobial agents. Journal of Taibah University for Science 18:1.
Read now
Hatim Soufi, Mohamed Moussaoui, Soukayna Baammi, Mouna Baassi, Mohammed Salah, Rachid Daoud, Achraf El Allali, M. E. Belghiti, Mohammed Moutaabbid & Said Belaaouad. (2024) Multi-combined QSAR, molecular docking, molecular dynamics simulation, and ADMET of Flavonoid derivatives as potent cholinesterase inhibitors. Journal of Biomolecular Structure and Dynamics 42:12, pages 6027-6041.
Read now
Youness Moukhliss, Yassine Koubi, Imran Zafar, Marwa Alaqarbeh, Hamid Maghat, Abdelouahid Sbai, Tahar Lakhlifi & Mohammed Bouachrine. Design of novel isoxazole derivatives as tubulin inhibitors using computer-aided techniques: QSAR modeling, in silico ADMETox, molecular docking, molecular dynamics, biological efficacy, and retrosynthesis. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Abdelmoujoud Faris, Ibrahim M. Ibrahim, Radwan Alnajjar, Hanine Hadni, Mashooq Ahmad Bhat, Muhammad Yaseen, Souvik Chakraborty, Nada Alsakhen, Israa M. Shamkh, Fazal Mabood, Ahmed M. Naglah, Ihsan Ullah, Noha Ziedan & Menana Elhallaoui. QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-30.
Read now
Abdelmoujoud Faris, Ivana Cacciatore, Ibrahim M. Ibrahim, Mohammed H. AL Mughram, Hanine Hadni, Kamal Tabti & Menana Elhallaoui. In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-23.
Read now

Articles from other publishers (6)

Uswatun Khasanah, Queen Intan Nurrahmah, Thia Amalia, Zada Nabila Putri, Imrokatul mufidah, Roisatun Napik, Diana Lyrawati, Bachtiar Rifai Pratita Ihsan & Maya Eka Febrianti. (2024) Oral acute toxicity study and in vivo antimalarial activity of Strychnos lucida R. Br. tablet. Journal of Ethnopharmacology 330, pages 118200.
Crossref
Abdelmoujoud Faris, Ivana Cacciatore, Radwan Alnajjar, Hadni Hanine, Adnane Aouidate, Ramzi A. Mothana, Abdullah R. Alanzi & Menana Elhallaoui. (2024) Revealing innovative JAK1 and JAK3 inhibitors: a comprehensive study utilizing QSAR, 3D-Pharmacophore screening, molecular docking, molecular dynamics, and MM/GBSA analyses. Frontiers in Molecular Biosciences 11.
Crossref
Cedric Dzidzor Kodjo Amengor, Prince Danan Biniyam, Abena Amponsaa Brobbey, Francis Klenam Kekessie, Felix Kwame Zoiku, Sherif Hamidu, Patrick Gyan & Billy Mawunyo Abudey. (2024) N-Substituted Phenylhydrazones Kill the Ring Stage of Plasmodium falciparum. BioMed Research International 2024, pages 1-13.
Crossref
Soukayna Baammi, Achraf El Allali & Rachid Daoud. (2023) Potent VEGFR-2 inhibitors for resistant breast cancer: a comprehensive 3D-QSAR, ADMET, molecular docking and MMPBSA calculation on triazolopyrazine derivatives. Frontiers in Molecular Biosciences 10.
Crossref
Soukayna Baammi, Achraf El Allali & Rachid Daoud. (2023) Unleashing Nature’s potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations. Frontiers in Molecular Biosciences 10.
Crossref
Abdelmoujoud Faris, Ibrahim M. Ibrahim, Omkulthom Al kamaly, Asmaa Saleh & Menana Elhallaoui. (2023) Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors. Molecules 28:15, pages 5914.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.